During a hearing before Congress over the EpiPen price hike scandal, Mylan CEO Heather Bresch called the outraged reactions to the price hike “overblown.” (AP photo)

EpiPen Maker Mylan Reveals Generic That’s Still Triple The Price

In yet another example of how Big Pharma hikes the prices of cheap drugs, Mylan CEO Heather Bresch has defended the price hikes, saying the company only received $274 of the total price for a twin-package while insurers, pharmacies and other parties divvy up the rest.